The store will not work correctly when cookies are disabled.
3-Hydroxy-1-methyl-5-((phenylamino)methyl)-1H-pyrazole-4-carboxylic acid
ID: ALA4514989
PubChem CID: 155539527
Max Phase: Preclinical
Molecular Formula: C12H13N3O3
Molecular Weight: 247.25
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1nc(O)c(C(=O)O)c1CNc1ccccc1
Standard InChI: InChI=1S/C12H13N3O3/c1-15-9(10(12(17)18)11(16)14-15)7-13-8-5-3-2-4-6-8/h2-6,13H,7H2,1H3,(H,14,16)(H,17,18)
Standard InChI Key: YXURSAIUJSPFDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
25.7919 -10.5826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4548 -10.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2004 -9.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3833 -9.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1289 -10.1047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9066 -8.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9035 -8.0955 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7919 -11.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9032 -8.6626 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6159 -9.3186 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1572 -10.5121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1556 -11.3292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8625 -11.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8586 -12.5561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5647 -12.9660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2741 -12.5587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2731 -11.7373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5664 -11.3311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
1 2 1 0
3 4 1 0
5 1 1 0
3 6 1 0
6 7 2 0
1 8 1 0
4 9 1 0
6 10 1 0
2 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 247.25 | Molecular Weight (Monoisotopic): 247.0957 | AlogP: 1.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 87.38 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.86 | CX Basic pKa: 3.56 | CX LogP: 1.34 | CX LogD: -2.74 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.76 | Np Likeness Score: -0.90 |
References
1. Pippione AC, Sainas S, Goyal P, Fritzson I, Cassiano GC, Giraudo A, Giorgis M, Tavella TA, Bagnati R, Rolando B, Caing-Carlsson R, Costa FTM, Andrade CH, Al-Karadaghi S, Boschi D, Friemann R, Lolli ML.. (2019) Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: Synthesis, biological evaluation and X-ray structural studies., 163 [PMID:30529545] [10.1016/j.ejmech.2018.11.044] |